Ernexa Therapeutics, Inc. (ERNA)
1.88
+0.05
(+2.73%)
USD |
NASDAQ |
Nov 06, 16:00
1.85
-0.03
(-1.60%)
After-Hours: 20:00
Ernexa Therapeutics Free Cash Flow : -8.878M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.878M |
| March 31, 2026 | -7.255M |
| December 31, 2025 | -7.054M |
| September 30, 2025 | -9.436M |
| June 30, 2025 | -14.45M |
| March 31, 2025 | -14.42M |
| December 31, 2024 | -16.20M |
| September 30, 2024 | -17.34M |
| June 30, 2024 | -16.86M |
| March 31, 2024 | -18.23M |
| December 31, 2023 | -20.43M |
| September 30, 2023 | -21.20M |
| June 30, 2023 | -21.54M |
| March 31, 2023 | -21.84M |
| December 31, 2022 | -21.27M |
| September 30, 2022 | -22.80M |
| June 30, 2022 | -23.07M |
| March 31, 2022 | -25.69M |
| December 31, 2021 | -23.64M |
| September 30, 2021 | -18.31M |
| June 30, 2021 | -14.29M |
| March 31, 2021 | -9.692M |
| December 31, 2020 | -8.14M |
| September 30, 2020 | -6.490M |
| June 30, 2020 | -3.936M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.494M |
| December 31, 2019 | 0.768M |
| September 30, 2019 | 0.974M |
| June 30, 2019 | 0.839M |
| March 31, 2019 | 0.629M |
| December 31, 2018 | -0.247M |
| September 30, 2018 | -1.294M |
| June 30, 2018 | -3.473M |
| March 31, 2018 | -0.68M |
| December 31, 2017 | -0.903M |
| September 30, 2017 | -0.167M |
| June 30, 2017 | 1.741M |
| March 31, 2017 | -0.676M |
| December 31, 2016 | -0.642M |
| September 30, 2016 | -2.744M |
| June 30, 2016 | -4.05M |
| March 31, 2016 | -7.051M |
| December 31, 2015 | -5.812M |
| September 30, 2015 | -7.079M |
| June 30, 2015 | -7.556M |
| March 31, 2015 | -6.754M |
| December 31, 2014 | -8.286M |
| September 30, 2014 | -5.094M |
| June 30, 2014 | -2.993M |
| March 31, 2014 | -1.612M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cerenome, Inc. | -23.55M |
| ACADIA Pharmaceuticals, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.152M |
| Cash from Investing (Quarterly) | -0.003M |
| Cash from Financing (Quarterly) | 0.006M |
| Free Cash Flow Per Share (Quarterly) | -3.512 |
| Free Cash Flow to Equity (Quarterly) | -4.115M |
| Free Cash Flow to Firm (Quarterly) | -4.155M |
| Free Cash Flow Yield | -721.5% |